Mixed strategies produce mixed results

Mixed strategies produce mixed results


3 June 2014 - Deborah Wilkes


This BRIEFING from OTCToolbox is designed to provide you with an easy way to compare the recent financial results of leading OTC businesses worldwide.

Around 60 pages long, the BRIEFING covers financial results reported by selected branded OTC players in 2013 and the first quarter of 2014. Key industry trends are identified in a feature article, while selected OTC businesses are covered in more detail in individual company results profiles.

OTC businesses featured in the BRIEFING are Bayer Consumer Care, Boehringer Ingelheim Consumer Health Care, GlaxoSmithKline Consumer Healthcare, Johnson & Johnson OTC, Merck & Co's Consumer Care unit, Merck KGaA's Consumer Health unit, Novartis Consumer Health, Omega Pharma, Pfizer Consumer Healthcare, Prestige Brands, Reckitt Benckiser, Sanofi Consumer Healthcare and Taisho Self-Medication.

Acquisitions, prescription-to-OTC switching and emerging markets all featured prominently in the recent financial results of branded OTC players. Furthermore, manufacturing problems continued to make their presence felt, as recalls and relaunches influenced fortunes. In addition, the low incidence of colds and flu in the first quarter of 2014 took its toll. The end result was a mixed bag of financial results for key OTC businesses worldwide.

This BRIEFING publication from OTCToolbox is written by OTC industry expert Deborah Wilkes. It is available to purchase and download immediately from the OTCToolbox website. Make sure your team is well informed through a Multiple User Licence or a Global Licence. The publication is also available as part of an Annual Subscription to the OTCToolbox website.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Briefings

Share this page: